Advanced Search

Neurosurgery Coding Alert

News Brief:

CMS Considers National Coverage for Bilateral Subthalamic Nucleus Stimulation

Published on Sun Sep 01, 2002

CMS is considering a national coverage determination for bilateral deep brain stimulation of the subthalamic nucleus or the globus pallidus interna for treatment of essential tremors in advanced Parkinson's disease patients. Now the Medicare Coverage Issues manual states only that Medicare coverage of deep brain stimulation by an implanted stimulator device "is not prohibited," and allows individual carriers to cover the procedure at their discretion. The move closely follows a Jan. 14, 2002, statement by the FDA approving the Medtronic Activa Parkinson's control therapy system for bilateral stimulation of the internal globus pallidus or the subthalamic nucleus for adjunctive therapy to reduce symptoms of advanced, levodopa-responsive Parkinson's disease unresponsive to medication. A CMS panel met on June 12 to discuss the issue, although a decision has yet to be announced. A favorable decision would ensure Medicare reimbursement for surgeons implanting bilateral brain stimulation devices for Parkinson's patients.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Neurosurgery Coding Alert

View All